Five Elms Capital
Five Elms leads UrgentIQ's $15 million Series A growth investment
Summary: A PR Newswire release provided by Five Elms Capital says UrgentIQ announced a $15 million Series A growth investment led by Five Elms. The release frames UrgentIQ as urgent-care EMR and AI workflow software; those product and growth claims should remain source-attributed and should not be treated as independent validation.
Why it matters: The update may matter to due-diligence readers as a public Five Elms activity signal in healthcare workflow software and vertical AI, while not establishing product efficacy, adoption, transaction economics, valuation, returns, or investment merit.
Summary
A PR Newswire release provided by Five Elms Capital says UrgentIQ announced a $15 million Series A growth investment led by Five Elms. The release describes UrgentIQ as software for urgent-care EMR and AI-enabled workflow use cases.
This draft treats the announcement as a Five Elms-supplied press release. Financing amount, Series A status, lead-investor role, product description, and healthcare workflow framing should remain attributed to the release rather than presented as independent 9AT validation.
Why it matters
For due-diligence readers, the useful signal is another public Five Elms growth-investment item in vertical software, this time tied to urgent-care operations and healthcare workflow tooling. That can help readers track manager activity by sector, software niche, and recurring growth-equity pattern.
The signal is bounded. The press release does not independently verify product efficacy, customer adoption, operating outcomes, valuation, ownership percentage, fund-level exposure, or future performance. Public adviser identity context does not validate UrgentIQ’s AI claims or support conclusions about transaction quality or investment suitability.
Source notes
- PR Newswire release provided by Five Elms Capital,
UrgentIQ Announces Strategic Growth Investment from Five Elms Capital: https://www.prnewswire.com/news-releases/urgentiq-announces-strategic-growth-investment-from-five-elms-capital-302876441.html - SEC Investment Adviser Public Disclosure profile for Five Elms Capital: https://adviserinfo.sec.gov/firm/summary/163548
- Source posture: source-party press release distributed through PR Newswire; acceptable for source-attributed facts about the announcement, but not independent validation of product, AI, adoption, or market claims.
- Verifier posture: the 2026-09-14 PM verifier cleared the item for drafting after body checks found UrgentIQ, Five Elms, $15 million, Series A, and urgent-care markers, with no same-event local post or draft.
- Editorial caveat: keep healthcare-software, EMR, AI, customer, and growth claims attributed to the release; avoid endorsement of UrgentIQ’s product or market framing.
9AT filing context
Public adviser/profile context reviewed by 9AT maps Five Elms Capital to CRD 163548, SEC file 801-110914, and about $3.1 billion in ADV-reported profile scale. That context supports broad adviser identity and background only.
The filing context does not identify the specific Five Elms vehicle involved in UrgentIQ, confirm the investment amount beyond the source announcement, validate healthcare workflow outcomes, prove AI functionality, measure customer adoption, or support any recommendation about UrgentIQ, Five Elms, or healthcare software investments. No 13F or Form 5500 context is included because those filings do not explain this private-company growth investment.
What to watch
Watch for later UrgentIQ or Five Elms disclosures that identify co-investors, governance changes, product rollout, measurable workflow outcomes, customer references, integration partnerships, or the specific investment vehicle.
Future coverage should maintain same-manager cadence discipline. Five Elms has several local software financing posts, so additional items should add a distinct source-backed event or be grouped into periodic activity coverage if the feed becomes crowded.